Utility of Anchored Multiplex PCR for gene fusion detection®

In this talk, Dr. Cecilia Yeung from the Fred Hutchinson Cancer Research Center discusses her experience using Anchored Multiplex PCR (AMP™) technology to identify fusions in leukemias. Dr. Yeung and her team used Archer® FusionPlex® tests to sequence myeloid and Acute Lymphoma Leukemia (ALL) samples. They were able to successfully detect point mutations, small indels and expression data using the Archer® Analysis bioinformatics platform. Additionally, Dr. Yeung used the RNA-based Archer® test in conjunction with a MinION® real-time sequencer (Oxford Nanopore Technologies) for rapid fusion detection. Watch the video to find out the results.

This video was recorded at the Cancer Genomics Consortium (CGC) annual meeting in August, 2018.

Utility of Anchored Multiplex PCR for gene fusion detection

 

This website stores cookies on your computer. These cookies are used to improve your website and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy.

We won’t track your information when you visit our site. But in order to comply with your preferences, we’ll have to use just one tiny cookie so that you’re not asked to make this choice again.